jurgenfr Shares of IDEXX Laboratories ( NASDAQ: IDXX ) fell 10% Thursday after the animal healthcare company lowered its 2024 revenue guidance due to slowed demand. For the third quarter, IDEXX ( IDXX ) reported revenue of $975.54M, missing the consensus estimate of $980.
96M. IDEXX also.
